Quantcast
 
New ETF Book by Larry Connors - Click here to read more


 

Zebra Technologies Releases of ISBT 128 Compliant Blood Bag Labels

Mon. October 20, 2008; Posted: 10:37 PM
Stocks RSS
SANTA BARBARA, Calif., Oct 20, 2008 (ASCRIBE NEWS via COMTEX) -- ZBRA | Quote | Chart | News | PowerRating -- Zebra Technologies, a provider of delivering on-demand specialty printing solutions for the healthcare industry, has introduced a new line of blood bag labels that support the ISBT 128 standard and are designed to enhance patient safety in the blood transfusion process.

Zebra's 8000T Primary Blood Bag labels are fully compliant with ISBT 128, the international standard for identification, labeling and information processing of human blood, tissue and organ products. Manufactured with a polypropylene face sheet, the 8000T Primary Blood Bag labels feature a durable, acrylic-based adhesive that meets FDA 175.105 requirements for indirect food contact. The strong adhesion and pliability of the labels enables them to easily and securely conform to the shape of the blood bag, helping to ensure ease of scanning and higher bar code read rates.

"Blood bag labels are a key component in improving patient safety throughout the blood transfusion process," said Cristina De Martini, global practice leader, healthcare, at Zebra Technologies. "By utilizing blood bag labels that comply with ISBT 128 blood bag labeling standards, blood banks are able to minimize the chance for mislabeling of blood products while ensuring that the labels remain readable throughout the blood supply chain. The release of our new blood bag labels demonstrates Zebra's ongoing commitment to delivering products that allow healthcare organizations to improve safety and enhance care delivery."

According to the FDA, approximately 414 blood transfusion errors occur in the United States each year. Damaged or illegible blood bag labels can hinder positive patient identification, leading to possible mismatches between the patient and blood product and compromising patient safety. A study published in the International Journal of Transfusion Medicine, "Sources of Preventable Errors Related to Transfusion," reports that nearly 80 percent of blood transfusion errors are related to bedside or labeling errors.

Designed for use with Zebra's thermal transfer printers, Zebra's blood bag label line includes both primary labels -- designed for placement directly on the blood bag -- and secondary labels, which are intended for placement on top of another blood bag label. Available in single quadrant, double quadrant and full face configurations, the labels withstand water, blood, soap, chemicals and other liquids for the duration of blood product storage. The long-lasting adhesive ensures that the labels will remain firmly affixed to the blood bag throughout its lifespan.

Zebra, a provider of print technology for the healthcare industry, is currently licensed by the International Council for Commonality in Blood Banking Automation (ICCBBA) as a registered vendor.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

((Distributed via M2 Communications Ltd - http://www.m2.com))

http://www.10meters.com

Comments on this story may be sent to newsdesk@closeupmedia.com

For full details on Zebra Technologies Cp A (ZBRA) click here. Zebra Technologies Cp A (ZBRA) has Short Term PowerRatings of 5. Details on Zebra Technologies Cp A (ZBRA) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [ZBRA]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.